The impairment of essential fatty acid metabolism as a key factor in doxorubicin-induced damage in cultured rat cardiomyocytes

被引:47
作者
Bordoni, A [1 ]
Biagi, PL [1 ]
Hrelia, S [1 ]
机构
[1] Dipartimento Biochim G Moruzzi, I-40126 Bologna, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 1999年 / 1440卷 / 01期
关键词
doxorubicin; cardiomyocyte; linoleic acid; alpha-linolenic acid; lipid peroxidation;
D O I
10.1016/S1388-1981(99)00113-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The clinical use of the antitumoral doxorubicin (DOX) is limited by its cardiotoxicity, which is mediated through different mechanisms. The membrane lipid peroxidation induced by DOX may cause disruption of the unsaturated fatty acyl chains; in the endoplasmic reticulum, containing the system catalyzing the desaturation/elongation of fatty acids, DOX could interfere with the metabolism of linoleic and alpha-linolenic acids. Using primary cultures of neonatal rat cardiomyocytes we demonstrated that the exposure to different concentrations of DOX (10(-5) and 10(-7) M) for 24 h caused an increase in the production of conjugated dienes, an impairment in the desaturation/elongation of essential fatty acids, and a reduction in the cellular content of highly unsaturated fatty acids. Conversely, 1 h exposure to 10(-5) M DOX was sufficient to induce alterations in the desaturation/elongation of linoleic and alpha-linolenic acids, but did not cause either formation of conjugated dienes or modification of the fatty acyl pattern. Therefore, DOX has a dual negative effect, depending on its concentration and on the time of exposure, one directed against the membrane highly unsaturated fatty acids, the other against the system which is required for the synthesis of these fatty acids themselves. These two effects synergically act in causing heart cell damage. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 29 条
[1]   Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits [J].
Arai, M ;
Tomaru, K ;
Takizawa, T ;
Sekiguchi, K ;
Yokoyama, T ;
Suzuki, T ;
Nagai, R .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (02) :243-254
[2]  
Arcamone F., 1981, DOXORUBICIN ANTICANC
[3]  
BENJAMIN RS, 1977, CANCER RES, V37, P1416
[4]  
BENJAMIN RS, 1993, CLIN PHARMACOL THER, V14, P592
[5]  
Bordoni A, 1996, MOL CELL BIOCHEM, V157, P217
[6]   FREE-RADICALS ALTER IONIC CALCIUM LEVELS AND MEMBRANE PHOSPHOLIPIDS IN CULTURED RAT VENTRICULAR MYOCYTES [J].
BURTON, KP ;
MORRIS, AC ;
MASSEY, KD ;
BUJA, LM ;
HAGLER, HK .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1990, 22 (09) :1035-1047
[7]   SEQUENCE-SELECTIVE TOPOISOMERASE-II INHIBITION BY ANTHRACYCLINE DERIVATIVES IN SV40 DNA - RELATIONSHIP WITH DNA-BINDING AFFINITY AND CYTOTOXICITY [J].
CAPRANICO, G ;
ZUNINO, F ;
KOHN, KW ;
POMMIER, Y .
BIOCHEMISTRY, 1990, 29 (02) :562-569
[8]   BINDING OF PRODUCTS ORIGINATING FROM THE PEROXIDATION OF LIVER MICROSOMAL LIPIDS TO THE NON-LIPID CONSTITUENTS OF THE MICROSOMAL MEMBRANE [J].
CASINI, AF ;
BENEDETTI, A ;
FERRALI, M ;
COMPORTI, M .
CHEMICO-BIOLOGICAL INTERACTIONS, 1979, 25 (2-3) :211-227
[9]   THE MITOCHONDRIAL PHOSPHATE CARRIER RECONSTITUTED IN LIPOSOMES IS INHIBITED BY DOXORUBICIN [J].
CHENEVAL, D ;
MULLER, M ;
CARAFOLI, E .
FEBS LETTERS, 1983, 159 (1-2) :123-126
[10]  
DEMANT EJF, 1983, EUR J BIOCHEM, V132, P551